IFRX InflaRx N.V.
Price Chart
Executive Summary
InflaRx N.V. announced it will release its Q4 and full-year 2025 financial and operating results on March 19, 2026, before market open. No conference call is planned. The press release contains no actual financial results or guidance.
Actionable Insight
Traders should await the actual earnings release on March 19, 2026. The absence of a conference call may limit near-term catalysts for volatility. Monitor for any pre-announcement signals or insider activity ahead of the release.
Key Facts
- InflaRx will release Q4 and full-year 2025 results on March 19, 2026, before market open.
- No earnings conference call is scheduled.
- No financial data, results, or guidance were disclosed in this announcement.
- The company is advancing izicopan and vilobelimab in inflammatory disease programs.
Financial Impact
No financial impact from this announcement — results not yet released.
Risk Factors
- Lack of a conference call may reduce transparency and limit investor engagement.
- Biotech earnings often carry high volatility; absence of management commentary could amplify uncertainty.
Market Snapshot
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3254509 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 6, 2026
17d ago
|
424B5
| $2.65 $2.52 | ▲ +4.91% | ▲ +6.41% | $2.61 (+1.51%) |
|
May 6, 2026
17d ago
|
6-K
| $2.50 $2.43 | ▼ −2.80% | ▼ −3.93% | $2.61 (+4.40%) |
|
May 6, 2026
17d ago
|
Press Release
| $2.50 $2.43 | ▼ −2.80% | ▼ −3.93% | $2.61 (+4.40%) |
|
May 6, 2026
17d ago
|
6-K
| $2.50 $2.43 | ▼ −2.80% | ▼ −3.93% | $2.61 (+4.40%) |
|
May 4, 2026
19d ago
|
6-K
| $1.97 $2.43 | ▲ +23.35% | ▲ +21.37% | $2.61 (+32.49%) |
|
May 1, 2026
22d ago
|
Press Release
| $2.10 $2.58 | ▲ +22.86% | ▲ +20.51% | $2.61 (+24.29%) |
|
Apr 23, 2026
4w ago
|
6-K
| $1.48 $2.07 | ▲ +39.86% | ▲ +38.96% | $2.61 (+76.35%) |
|
Apr 9, 2026
6w ago
|
Press Release
| $1.03 $1.20 | ▲ +16.50% | ▲ +13.32% | $2.61 (+153.40%) |
|
Mar 19, 2026
9w ago
|
Press Release
| $0.9100 $0.9300 | ▲ +2.20% | ▲ +4.41% | $2.61 (+186.81%) |
|
Mar 18, 2026
9w ago
|
Press Release
| $0.8800 $0.9400 | ▲ +6.82% | ▲ +7.53% | $2.61 (+196.59%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access